Uneingeschränkter Zugang

Shared decision-making for gene therapy in haemophilia care

Simon Fletcher

Simon Fletcher

Haemnet LtdLondon, UK
Orcid-Profil
Suche nach diesem Autor auf
Sciendo|Google Scholar
Fletcher, Simon
, 
Kathryn Jenner

Kathryn Jenner

Haemnet LtdLondon, UK
Orcid-Profil
Suche nach diesem Autor auf
Sciendo|Google Scholar
Jenner, Kathryn
 und 
Kate Khair

Kate Khair

Haemnet LtdLondon, UK
Orcid-Profil
Suche nach diesem Autor auf
Sciendo|Google Scholar
Khair, Kate
  
09. Aug. 2023
Shared decision-making for gene therapy in haemophilia care's Cover Image
Über diesen Artikel
Vorheriger Artikel
Nächster Artikel
Zitieren
COVER HERUNTERLADEN
Artikel-Kategorie: Clinical Practice
Online veröffentlicht: 09. Aug. 2023
Seitenbereich: 62 - 67
DOI: https://doi.org/10.2478/jhp-2023-0009
Schlüsselwörter
© 2023 Simon Fletcher et al., published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.
Education and support during the shared decision-making process is key to ensuring that people with haemophilia are able to make informed therapeutic choices as gene therapy becomes more widely available as a treatment option
Education and support during the shared decision-making process is key to ensuring that people with haemophilia are able to make informed therapeutic choices as gene therapy becomes more widely available as a treatment option

Figure 1.

The patient decision-making journey in the current treatment landscape (cf. Wang et al., 2022) [19]
The patient decision-making journey in the current treatment landscape (cf. Wang et al., 2022) [19]
Sprache:
Englisch
Zeitrahmen der Veröffentlichung:
1 Hefte pro Jahr
Fachgebiete der Zeitschrift:
Medizin, Vorklinische Medizin, Grundlagenmedizin, Vorklinische Medizin, Grundlagenmedizin, andere, Klinische Medizin, Klinische Medizin, andere, Pharmazie, Pharmakologie
Zeitschrift RSS Feed